Bellerophon Therapeutics Llc (BLPH)

Trade BLPH now with
12/17/2019 7:07:14 AM Bellerophon Announces Positive Top-line Results From Cohort 2 Of Ongoing Phase 2/3 Clinical Study Of INOpulse
9/16/2019 8:36:08 AM Bellerophon Therapeutics: FDA Granted Orphan Drug Designation To Nitric Oxide
9/16/2019 8:34:27 AM Bellerophon Receives Orphan Drug Designation For Nitric Oxide In The Treatment Of Idiopathic Pulmonary Fibrosis
8/1/2019 8:39:40 AM Bellerophon Completes Enrollment In Cohort 2 Of Phase 2/3 Study Of INOpulse
1/25/2019 4:11:08 PM Bellerophon Announces Closing Of $7 Mln Public Offering Of Common Stock
1/23/2019 6:01:35 AM Bellerophon Therapeutics Prices Public Offering Of 10 Mln Shares At $0.70 Per Share
1/22/2019 4:48:58 PM Bellerophon Therapeutics Announces Proposed Public Offering Of Common Stock
1/7/2019 8:36:14 AM Bellerophon Therapeutics Reports Top-line Results From Cohort 1 Of INOpulse Phase 2b Clinical Trial
11/7/2018 8:36:43 AM Bellerophon Therapeutics Q3 Net Income $11.1 Mln Or $0.19/shr Vs. Net Loss Of $7.6 Mln Or $0.22/shr Prior Year
5/10/2018 8:47:57 AM Bellerophon Therapeutics Q1 Net Income $4.1 Mln Or $0.07/shr Vs Net Loss Of $19.1 Mln Or $0.60/shr Prior Year
5/8/2018 8:36:11 AM Bellerophon Reaches Agreement With FDA On Study Design Of Phase 2b Trial Of INOpulse